By March 31, 2025: Billing team and providers must review all 40+ updated laboratory policies on Avalon Healthcare Solutions website (https://www.avalon-healthcare.com or through CareSource Provider Portal). Immediately register and test claims using the Trial Claim Advice Tool on the CareSource Provider Portal to simulate compliance with new policies before April 1, 2025. Update laboratory ordering procedures and billing workflows to ensure claims for Flow Cytometry, Cervical Cancer Screening, Prostate Biopsy Analysis, Prenatal Screening, Hepatitis Testing, Celiac Disease Testing, Thyroid Testing, Alzheimer biomarkers, Cardiovascular Risk Assessment, Bone Turnover Markers, Breast Cancer Risk Assessment, Fecal Analysis, TB Testing, Chemoresistance Assays, Therapeutic Antibody Monitoring, Hepatic Fibrosis Testing, Oral Cancer Screening, Thiopurine Metabolites, Influenza Diagnostics, IBD Testing, Multiple Sclerosis Biomarkers, Tumor Markers, Pathogen Panels, Cardiac Biomarkers, TBI Testing, Pancreatic Enzymes, Folate Testing, Inflammation Testing, Urine Culture, Vector-Borne Infections, Beta-Hemolytic Streptococcus, Gamma-glutamyl Transferase, Thrombosis Risk Testing, Alpha-1 Antitrypsin, Microorganism Identification, and Nerve Fiber Density Testing comply with Avalon's clinical editing criteria. Failure to comply will result in claim denials or payment delays post-service. Communicate policy changes to all providers ordering laboratory tests.